Stepwise target controllability identifies dysregulations of macrophage networks in multiple sclerosis
Violetta ZUJOVIC, INSERM researcher and Team Leader and Fabrizio De VICO FALLANI, INRIA researcher at the Paris Brain Institute just published in Network Neuroscience. Identifying the nodes able to drive the state of a network is crucial to...
05.06.2021
Research, science & health
Definition of new forms of the behavioural variant of frontotemporal degenerations (FTD)
Frontotemporal degeneration (FTD) is a complex neurodegenerative disorder that can manifest itself through a wide range of symptoms. Valérie Godefroy, postdoctoral researcher in the Frontlab, under the supervision of Lara Migliaccio, and her...
05.05.2021
Research, science & health
Jaime DE JUAN-SANZ, team leader at the Paris Brain Institute, selected for the FENS-Kavli Scholars
The FENS-Kavli Network (FKNE) is pleased to announce the recruitment of the new 2021 cohort of FENS-Kavli Scholars. In 2014, FENS and the Kavli Foundation announced the FENS-Kavli Network of Excellence: a group of early career, independent...
04.21.2021
Events
A new non-invasive therapy for the treatment of Primary Orthostatic Tremor (POT): Trans-spinal electrical stimulation
Primary orthostatic tremor (POT) is a rare and poorly understood neurological disorder. It presents as a very rapid tremor (not visible to the naked eye) of the legs and trunk, causing a feeling of instability and fear of falling. The symptoms appear...
04.19.2021
Research, science & health
Pierre Nectoux, co-founder of Wefight, named to the "30 Under 30" ranking by Forbes France magazine
Forbes France magazine unveiled in its latest issue the ranking of its fifth edition "30 Under 30". This ranking is dedicated to a new generation of entrepreneurs who disrupt the codes of their field: sports, finance, art, entertainment, environment...
04.13.2021
Research applications
Specific patterns identified by electroencephalography in patients infected with sars-cov-2
Neurological disorders have been reported in patients with Covid-19. Researchers and clinicians from the Paris Brain Institute and the Hôpital Pitié-Salpêtrière AP-HP have shown the interest of combining different examinations with...
04.08.2021
Research, science & health
Opening of a new domain: computational modelling in neuroscience
The objective of the new scientific domain ( Computational modelling in neuroscience) is to recognise the particular interdisciplinary experience of some researchers at Paris Brain Institute. Up to now people using a computational neuroscience...
03.29.2021
Institutional
Non-invasive brain stimulation for neurodegenerative diseases
Non-invasive brain stimulation is a rapidly expanding field with promising leads for the treatment of neurodegenerative diseases. Within the Frontlab of the Paris Brain Institute, Clara Sanches, a doctoral student, Dr. Lara Migliaccio (Inserm) and Dr...
03.25.2021
Research, science & health
Obesity and response to food marketing
Researchers from the Paris Brain Institute, INSEAD, the Nutrition Department of the Pitié-Salpêtrière Hospital (AP-HP/Sorbonne Université), EPHE and the University of British Columbia, provide new evidence for a reciprocal relationship between...
03.13.2021
Research, science & health
Weight loss and reward brain system
A study conducted by Liane Schmidt (INSERM) and Hilke Plassmann (INSEAD’s Octapharma Chaired Professor of Decision Neuroscience) both researchers at the Paris Brain Institute establishes for the first time a link between weight loss, the connectivity...
03.12.2021
Research, science & health
The Paris Brain Institute signs the ALBA declaration on equity and inclusion
By signing this declaration, the Paris Brain Institute is now part of network of more than 150 scientific organisations committed to more diversity and equity in the scientific world.
01.22.2021
Institutional
New European alliance formed to tackle urgent challenge of neurodegenerative diseases
Top research institutes from Germany, France, Belgium and the UK have formed a new alliance to combat neurodegenerative diseases. Their mission? Catalysing a United Response in Europe to Neurodegenerative Diseases, or CURE-ND for short.
12.17.2020
Institutional